SynopsisA denture is commonly known as false teeth as it replaces missing natural teeth. It can be made of plastic The global Plastic Tooth market size is expected to reach US$ 99.8 million by 2029, growing at a CAGR of 5.6% from 2023 to 2029. The market is main.....
SynopsisStent grafts play a limited role in the treatment of peripheral obstructive disease. Stent grafts are stent bodies carrying a full jacket coating around their surface. The global Coated Stent Graft market size is expected to reach US$ 1895.9 million by 2.....
SynopsisStent graft systems for the treatment of the aortic arch and the thoracic aorta. The global Thoracic Stent Graft market size is expected to reach US$ 246.9 million by 2029, growing at a CAGR of 3.4% from 2023 to 2029. The market is mainly driven by the s.....
SynopsisRITUXAN is a type of antibody therapy that can be used alone or with chemotherapy. The global Rituxan market size is expected to reach US$ 469.8 million by 2029, growing at a CAGR of -10.5% from 2023 to 2029. The market is mainly driven by the significan.....
SynopsisREVLIMID® (lenalidomide), an immunomodulatory therapy used to treat people with multiple myeloma The global Revlimid market size is expected to reach US$ 6006.3 million by 2029, growing at a CAGR of -5.2% from 2023 to 2029. The market is mainly driven by.....
SynopsisRituximab is a type of antibody therapy that can be used alone or with chemotherapy. The global Rituximab market size is expected to reach US$ 6006.3 million by 2029, growing at a CAGR of -5.2% from 2023 to 2029. The market is mainly driven by the signif.....
SynopsisAfinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures. The global Afinitor market size is expected to reach US$ 255.2 million by 2029, growing at a CAGR of -7.6% from 2023 to 2029.....
SynopsisAfinitor (everolimus) is a brand-name prescription medication. It's used to treat certain types of cancers, tumors, and seizures. The global Everolimus market size is expected to reach US$ 255.2 million by 2029, growing at a CAGR of -7.6% from 2023 to 20.....
SynopsisTASIGNA can be prescribed to treat Philadelphia chromosome-positive chronic myeloid leukemia. The global Tasigna market size is expected to reach US$ 1200.7 million by 2029, growing at a CAGR of -5.4% from 2023 to 2029. The market is mainly driven by the.....
SynopsisNilotinib is a type of targeted cancer drug called a tyrosine kinase inhibitor (TKI). The global Nilotinib market size is expected to reach US$ 1200.7 million by 2029, growing at a CAGR of -5.4% from 2023 to 2029. The market is mainly driven by the sign.....
